This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Tunisia, United Kingdom
The drug PROCORALAN contains one active pharmaceutical ingredient (API):
1
Ivabradine
UNII TP19837BZK - IVABRADINE HYDROCHLORIDE
|
Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PROCORALAN Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C01EB17 | Ivabradine | C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 531302101111218, 531302102118216, 531302103114214, 531302104110212 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00434721, 00434738, 00673087, 01688122, 01689110, 02256778, 03879151, 03879814, 03880556, 03880579, 05389310, 06441403, 06441426, 07577754, 10004795, 10004803, 10004826, 10130850, 10203218, 10321053, 10321076, 10321082, 10402426, 10526051, 10554515, 10554538, 11214170, 11226799, 11258210, 11542595, 12381295, 12389279, 13862513, 15266301, 15619774, 16031681, 16031698, 17368968, 17421421 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 27.819-11-07, 27.872-10-07 |
Country: EE | Ravimiamet | Identifier(s): 1219463, 1219474, 1219485, 1219496, 1219508, 1219519, 1219520, 1219531, 1219542, 1219553, 1219564, 1219575, 1219586, 1219597 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 05316003, 05316003IP, 05316003IP1, 05316010, 05316010IP, 05316010IP1, 05316010IP2 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 041086, 041096, 041105, 041114 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61952527, 63501124 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 375319, 381637, 381639, 98303, 98306 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 42703, 42704, 42706, 42710, 42720, 42721, 42725, 42774 |
Country: IT | Agenzia del Farmaco | Identifier(s): 037061013, 037061025, 037061037, 037061049, 037061052, 037061064, 037061076, 037061088, 037061090, 037061102, 037061114, 037061126, 037061138, 037061140 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1030448, 1030449, 1030450, 1030451, 1030452, 1030453, 1030454, 1030455, 1030456, 1030457, 1030458, 1030459, 1030460, 1030461 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 204M2007 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 198161, 198188 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100147059, 100147065 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6353171, 6353172 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.